SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2

Published:2019-01 Issue: Volume:109 Page:1327-1338
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhou Ying,Fan Jinjin,Zheng Chenfei,Yin Peiran,Wu Haishan,Li Xiaoyan,Luo Ning,Yu Xueqing,Chen Chaosheng

Funder

Wenzhou Committee of Science and Technology of China

Zhejiang Province Natural Science Foundation

Guangdong Medical Science and Technology Research Fund Project of China

Guangzhou Science and Technology Project of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference34 articles.

1. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends;Grassmann;Nephrol. Dial Transpl.,2005

2. Renal replacement therapy in Europe-a summary of the 2010 ERA-EDTA Registry Annual Report;Kramer;Clin. Kidney J.,2013

3. Basic mechanisms and clinical implications of peritoneal fibrosis;Margetts;Peritoneal Dialysis Int.,2003

4. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton’s jelly in the treatment of rat peritoneal dialysis-induced fibrosis;Fan;Stem Cells Transl. Med.,2016

5. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta1 signaling;Ueno;Kidney Int.,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empagliflozin attenuates epithelial-to-mesenchymal transition through senescence in peritoneal dialysis;American Journal of Physiology-Renal Physiology;2024-09-01

2. SGLT-2 inhibitors in chronic peritoneal dialysis patients: a follow-up study;BMC Nephrology;2024-07-29

3. Effects of Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic and Non-Diabetic Patients with Advanced Chronic Kidney Disease in Peritoneal Dialysis on Residual Kidney Function: In Real-World Data;Medicina;2024-07-24

4. Peritoneal Glucose Uptake Reduction by Sodium-Glucose Co-Transporter 2 Inhibitors in Clinical Peritoneal Dialysis;Blood Purification;2024-04-29

5. Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge;International Journal of Molecular Sciences;2024-03-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3